February 5, 2022 Comments Off on New patent for Amarin Pharms drug VASCEPA Posted in: Patent Added Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are sixty-six patents…
The post New patent for Amarin Pharms drug VASCEPA appeared first on Dru…
February 4, 2022 Comments Off on New patent for On Target drug CYTALUX Posted in: Patent Added Annual Drug Patent Expirations for CYTALUX Cytalux is a drug marketed by On Target Labs and is included in one NDA. The generic ingredient in CYTALUX is pafolacianine sodium. Additional…
The post New patent for On Target drug CYTALUX appeared first on …
